IMU 2.06% 9.5¢ imugene limited

some opinion on iimugene

  1. 7,266 Posts.
    lightbulb Created with Sketch. 331
    THE CAFE TAKE - 22/08/2005

    Imugene Limited - 40 Billion Fatter Chooks
    View Archive


    There could be 40 billion fatter chickens if innovative Australian company Imugene has its way. It‘s in the product development phase of commercialising its Poultry Productivity Enhancer. Put simply it‘s a remarkable additive to poultry that in early trials has shown a 13 - 17% increase in size.

    The product enhances poultry growth and weight gain together with improved feed conversion rates. It is biologically extremely safe. Whether it is Woolworths or Kentucky Fried Chicken buying chickens for our insatiable demand for white meat, they all want safe, healthy and cheap chicken meat. The chicken producers all want to increase their efficiencies to improve returns as well as satisfying consumers desires.

    Imugene is led by executive chairman, Graham Dowland , and CEO Dr. Warwick Lamb , their combined take-home salary is only a little over $300,000 for a very challenging job. In addition the benefit of veterinary biotechnology products is that they are simpler and easier to get to market with less regulation and less challenges. Imugene‘s poultry productivity enhancer vaccine has completed all pre-regulatory trials successfully and will soon go into a large scale commercial trial. This is the last step in proving that the product works.

    So how will Imugene get the product to the 40 billion chickens? Imugene are smart enough to realise that they shouldn‘t be using shareholders funds opening offices, hiring sales forces and running expensive marketing campaigns around the world. Selling veterinary products is a specialised industry and it would entail a very high cost before there was any return for shareholders. As such they are in active discussion with Merial.

    Merial is the world‘s second largest manufacturer and distributor of veterinary products and would be a superb partner. They have signed a first stage agreement and now there are only relatively minor details to be completed. Why would Merial want to take on the Imugene product?

    Well a little known fact is that less than 1% of veterinary products gross over $1 million a year in sales. Imugene‘s chook booster has tremendous potential. Estimates of world wide potential sales vary from US $200 million to US $600 million, quiet simply it would be a blockbuster drug for Merial. Merial also see that this is a product in the last 25m of a 400 metre race.

watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Mkt cap ! $461.6M
Open High Low Value Volume
9.7¢ 9.7¢ 9.2¢ $1.134M 11.89M

Buyers (Bids)

No. Vol. Price($)
4 196473 9.5¢

Sellers (Offers)

Price($) Vol. No.
9.6¢ 30425 1
View Market Depth
Last trade - 15.22pm 05/03/2021 (20 minute delay) ?
-0.002 ( 2.56 %)
Open High Low Volume
9.6¢ 9.7¢ 9.2¢ 2646904
Last updated 15.37pm 05/03/2021 (live) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.